Astellas, JFCR Unite for Cancer Research
Astellas Pharma Inc. and Japanese Foundation for Cancer Research announced they have entered into a strategic collaboration to accelerate translational and clinical oncology research.
The collaboration leverages Astellas’ unique scientific, translational and clinical expertise and JFCR’s strength as a world-class comprehensive cancer research center to quickly advance the development of novel treatments for patients with cancers that are resistant to current therapies. Under the agreement, projects will be selected jointly based on shared interest and expertise. Selected projects will generate new translational and clinical data for Astellas’ early-stage pipeline assets, which will be integrated with Astellas’ own data to accelerate and refine these programs. Through this collaboration, Astellas is committed to strengthening translational science and clinical research in order to deliver innovative new medicines. For JFCR, the collaboration provides early access to Astellas’ pipeline, along with additional resources and expertise to bring these therapies to patients.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
